Our recent activity

Asabys Partners da entrada al FEI y eleva su primer fondo a 117 millones

PortfolioiPremom raises €15m to transform pregnancy care with molecular diagnostics
September 2, 2026

iPremom raises €15m to transform pregnancy care with molecular diagnostics

READ THIS NEWS IN SPANISH iPremom, a molecular diagnostics company dedicated to the earliest prediction of pregnancy complications, has raised €15m in seed funding led by Amadeus Capital Partners, co-led…
PortfolioOriva Therapeutics appoints Dr Agnès Arbat as CEO to advance clinical-stage women’s health pipeline
June 11, 2026

Oriva Therapeutics appoints Dr Agnès Arbat as CEO to advance clinical-stage women’s health pipeline

READ THIS NEWS IN SPANISH Oriva is developing innovative medicines for chronic gynaecological diseases and is backed by pre-seed financing from Asabys Partners’ Sabadell Asabys II fund Dr Arbat brings…
PortfolioOna Therapeutics Raises $86.6 Million Series B to Advance First-in-Class ADCs into Clinical Development
June 4, 2026

Ona Therapeutics Raises $86.6 Million Series B to Advance First-in-Class ADCs into Clinical Development

READ THIS NEWS IN SPANISH Oversubscribed Series B financing co-led by new investors Columbus Venture Partners and Mérieux Equity Partners, with participation from additional investors COFIDES and Korys, alongside all…